ALIGOS THERAPEUTICS INC's ticker is ALGS and the CUSIP is 01626L105. A total of 37 filers reported holding ALIGOS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $506 | -23.0% | 677 | 0.0% | 0.00% | – |
| Q2 2023 | $657 | -34.3% | 677 | 0.0% | 0.00% | – |
| Q1 2023 | $1,000 | +99900.0% | 677 | 0.0% | 0.00% | – |
| Q4 2022 | $1 | -100.0% | 677 | -82.2% | 0.00% | – |
| Q3 2022 | $5,000 | +150.0% | 3,802 | +141.9% | 0.00% | – |
| Q2 2022 | $2,000 | -93.5% | 1,572 | -89.3% | 0.00% | – |
| Q1 2022 | $31,000 | -81.8% | 14,674 | +2.0% | 0.00% | – |
| Q4 2021 | $170,000 | -30.3% | 14,383 | -8.3% | 0.00% | – |
| Q3 2021 | $244,000 | -53.9% | 15,684 | -39.5% | 0.00% | – |
| Q2 2021 | $529,000 | -21.3% | 25,909 | -12.3% | 0.00% | – |
| Q1 2021 | $672,000 | -38.8% | 29,535 | -25.6% | 0.00% | – |
| Q4 2020 | $1,098,000 | – | 39,684 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 2,320,381 | $47,301,000 | 15.67% |
| Pivotal bioVenture Partners Investment Advisor LLC | 876,548 | $17,873,000 | 7.04% |
| Vivo Capital, LLC | 3,547,030 | $72,306,000 | 3.13% |
| Novo Holdings A/S | 2,614,563 | $53,311,000 | 2.36% |
| ACUTA CAPITAL PARTNERS, LLC | 214,254 | $4,368,000 | 1.75% |
| Boxer Capital, LLC | 1,526,048 | $31,108,000 | 1.10% |
| VR Adviser, LLC | 408,377 | $8,325,000 | 1.01% |
| Cormorant Asset Management, LP | 905,467 | $18,458,000 | 0.63% |
| HHLR ADVISORS, LTD. | 2,165,064 | $44,135,000 | 0.45% |
| Logos Global Management LP | 212,785 | $4,339,000 | 0.36% |